Development and external validation of a dynamic nomogram for predicting the risk of functional outcome after 90 days in patients with acute intracerebral hemorrhage.

Shaojie Li, Hongjian Li, Jiani Chen, Baofang Wu, Jiayin Wang, Chaocan Hong, Changhu Yan, Weizhi Qiu, Yasong Li, Hongzhi Gao
Author Information
  1. Shaojie Li: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
  2. Hongjian Li: Department of Radiology, Affiliated Hospital of North Sichuan Medical College, North Sichuan Medical College, Nanchong, China.
  3. Jiani Chen: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
  4. Baofang Wu: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
  5. Jiayin Wang: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
  6. Chaocan Hong: Department of Neurosurgery, Jinjiang Hospital of Traditional Chinese Medicine, Quanzhou, China.
  7. Changhu Yan: Department of Neurosurgery, Jinjiang Hospital of Traditional Chinese Medicine, Quanzhou, China.
  8. Weizhi Qiu: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
  9. Yasong Li: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
  10. Hongzhi Gao: Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

Abstract

Background and purpose: Intracerebral hemorrhage remains a significant cause of death and disability worldwide, highlighting the urgent need for accurate prognostic assessments to optimize patient management. This study aimed to develop a practical nomogram for risk prediction of poor prognosis after 90 days in patients with intracerebral hemorrhage.
Methods: A retrospective study was conducted on 638 patients with intracerebral hemorrhage in the Second Hospital of Fujian Medical University, China, who were divided into a training set ( = 446) and a test set ( = 192) by random splitting. Then the data on demographics, clinical symptoms, imaging characteristics, and laboratory findings were collected. In this study, adverse outcomes were defined as a Modified Rankin Scale (mRS) score of 3-6 at 90 days post-ICH onset, as assessed during follow-up. Later, least absolute shrinkage and selection operator (LASSO) regression and multifactorial logistic regression were used to screen the variables and construct a nomogram. Next, the evaluation was performed using the Receiver Operating Characteristic (ROC) curve, calibration curve, and decision curve analysis. Finally, the external validation was completed using the data of 496 patients with intracerebral hemorrhage from the Jinjiang Hospital of Traditional Chinese Medicine.
Results: In the training and test sets of intracerebral hemorrhage, the incidence of poor prognosis was 60.53 and 61.46%, respectively. Through variable screening, this study identified age, Glasgow Coma Scale (GCS), blood glucose, uric acid, hemoglobin, and hematoma location as independent predictors of poor prognosis in intracerebral hemorrhage. The developed dynamic nomogram was easy to use and demonstrated strong predictive performance (training set AUC: 0.87; test set AUC: 0.839; external validation set AUC: 0.774), excellent calibration, and clinical applicability.
Conclusion: The dynamic nomogram we developed using five independent risk factors serves as a practical tool for real-time risk assessment and can help facilitate early intervention and personalized patient management, thereby improving clinical outcomes in high-risk patients.

Keywords

References

  1. Neurology. 2016 Jul 26;87(4):357-64 [PMID: 27343067]
  2. Proteomics. 2012 Jan;12(1):113-23 [PMID: 22065606]
  3. Stroke. 2003 Sep;34(9):2091-6 [PMID: 12907817]
  4. Clin Interv Aging. 2024 Aug 09;19:1423-1436 [PMID: 39139210]
  5. Circulation. 2017 Feb 21;135(8):759-771 [PMID: 28052979]
  6. Front Neurol. 2022 Sep 16;13:915813 [PMID: 36188383]
  7. Sci Rep. 2023 Aug 3;13(1):12580 [PMID: 37537270]
  8. Sci Rep. 2024 Aug 9;14(1):18546 [PMID: 39122887]
  9. BMC Neurol. 2022 Jun 27;22(1):236 [PMID: 35761206]
  10. Infect Drug Resist. 2024 Sep 05;17:3863-3877 [PMID: 39253609]
  11. Neurosurg Rev. 2023 Jun 5;46(1):135 [PMID: 37273079]
  12. J Pain Res. 2024 Oct 02;17:3241-3253 [PMID: 39371492]
  13. Front Neurol. 2018 Aug 28;9:725 [PMID: 30210444]
  14. J Inflamm Res. 2024 Sep 30;17:6905-6916 [PMID: 39372594]
  15. J Neurosurg. 2023 Aug 11;140(3):755-763 [PMID: 37721414]
  16. J Craniofac Surg. 2024 Jun 1;35(4):1181-1185 [PMID: 38595184]
  17. Lancet Neurol. 2021 Oct;20(10):795-820 [PMID: 34487721]
  18. Electrolyte Blood Press. 2014 Jun;12(1):1-6 [PMID: 25061467]
  19. Hepatology. 2022 May;75(5):1348-1349 [PMID: 35092078]
  20. Neurol Res. 2023 Sep;45(9):827-834 [PMID: 37170802]
  21. J Am Heart Assoc. 2023 Jun 6;12(11):e028816 [PMID: 37232240]
  22. Lancet Neurol. 2024 Oct;23(10):973-1003 [PMID: 39304265]
  23. BMC Complement Med Ther. 2024 Oct 10;24(1):364 [PMID: 39390478]
  24. J Med Life. 2021 Sep-Oct;14(5):606-619 [PMID: 35027963]
  25. Neurosurg Rev. 2024 Sep 4;47(1):528 [PMID: 39227406]
  26. J Proteome Res. 2024 Oct 4;23(10):4369-4383 [PMID: 39225497]
  27. Front Neurol. 2021 Dec 15;12:747551 [PMID: 34975715]
  28. Neuropsychiatr Dis Treat. 2024 Oct 03;20:1879-1887 [PMID: 39376667]
  29. PLoS One. 2024 Jun 3;19(6):e0296616 [PMID: 38829877]
  30. Front Neurol. 2023 Nov 23;14:1268627 [PMID: 38073656]
  31. Neurol Sci. 2024 Jun;45(6):2747-2757 [PMID: 38267601]
  32. Ecotoxicol Environ Saf. 2024 Oct 15;285:117093 [PMID: 39317070]
  33. Clin Neurol Neurosurg. 2024 Nov;246:108576 [PMID: 39366160]
  34. Nat Med. 2011 Feb;17(2):206-10 [PMID: 21258336]
  35. Crit Care. 2013 Jul 23;17(4):R148 [PMID: 23880122]
  36. Neurocrit Care. 2024 Aug 27;: [PMID: 39192100]
  37. Stroke. 2014 Nov;45(11):3433-5 [PMID: 25316277]
  38. Lancet Neurol. 2011 Aug;10(8):702-9 [PMID: 21741316]

Word Cloud

Created with Highcharts 10.0.0hemorrhageintracerebralnomogrampatientssetstudyriskprognosisexternalvalidationdynamicpoor90 daystrainingtestclinicalusingcurveAUC:0patientmanagementpracticalpredictionHospitaldataoutcomesScaleregressioncalibrationindependentdevelopedBackgroundpurpose:IntracerebralremainssignificantcausedeathdisabilityworldwidehighlightingurgentneedaccurateprognosticassessmentsoptimizeaimeddevelopMethods:retrospectiveconducted638SecondFujianMedicalUniversityChinadivided = 446 = 192randomsplittingdemographicssymptomsimagingcharacteristicslaboratoryfindingscollectedadversedefinedModifiedRankinmRSscore3-6post-ICHonsetassessedfollow-upLaterleastabsoluteshrinkageselectionoperatorLASSOmultifactoriallogisticusedscreenvariablesconstructNextevaluationperformedReceiverOperatingCharacteristicROCdecisionanalysisFinallycompleted496JinjiangTraditionalChineseMedicineResults:setsincidence60536146%respectivelyvariablescreeningidentifiedageGlasgowComaGCSbloodglucoseuricacidhemoglobinhematomalocationpredictorseasyusedemonstratedstrongpredictiveperformance87839774excellentapplicabilityConclusion:fivefactorsservestoolreal-timeassessmentcanhelpfacilitateearlyinterventionpersonalizedtherebyimprovinghigh-riskDevelopmentpredictingfunctionaloutcomeacute

Similar Articles

Cited By